Your browser doesn't support javascript.
loading
Anti-Inflammatory Activity of the Constituents from the Leaves of Perilla frutescens var. acuta.
Youn, Isoo; Han, Sujin; Jung, Hee Jin; Noh, Sang Gyun; Chung, Hae Young; Koo, Yean Kyoung; Shin, Sunhye; Seo, Eun Kyoung.
Afiliação
  • Youn I; Graduate School of Pharmaceutical Sciences, College of Pharmacy, Ewha Womans University, Seoul 03760, Republic of Korea.
  • Han S; Graduate School of Pharmaceutical Sciences, College of Pharmacy, Ewha Womans University, Seoul 03760, Republic of Korea.
  • Jung HJ; Department of Pharmacy, College of Pharmacy, Pusan National University, Busan 46241, Republic of Korea.
  • Noh SG; Department of Pharmacy, College of Pharmacy, Pusan National University, Busan 46241, Republic of Korea.
  • Chung HY; Department of Pharmacy, College of Pharmacy, Pusan National University, Busan 46241, Republic of Korea.
  • Koo YK; Department of R&I Center, COSMAXBIO, Seongnam 13487, Republic of Korea.
  • Shin S; Major of Food and Nutrition, Division of Applied Food System, Seoul Women's University, Seoul 01797, Republic of Korea.
  • Seo EK; Graduate School of Pharmaceutical Sciences, College of Pharmacy, Ewha Womans University, Seoul 03760, Republic of Korea.
Pharmaceuticals (Basel) ; 16(12)2023 Nov 28.
Article em En | MEDLINE | ID: mdl-38139782
ABSTRACT
Perilla frutense var. acuta (Lamiaceae) has been used to treat indigestion, asthma, and allergies in traditional medicine. In this study, luteolin 7-O-diglucuronide (1), apigenin 7-O-diglucuronide (2), and rosmarinic acid (3) were isolated from the leaves of P. frutescens var. acuta through various chromatographic purification techniques. Several approaches were used to investigate the anti-inflammatory activity of the constituents (1-3) and their working mechanisms. In silico docking simulation demonstrated that 1-3 would work as a PPAR-α/δ/γ agonist, and in vitro PPAR-α/δ/γ transcriptional assay showed that the Perilla water extract (PWE) and 3 increased PPARluciferase activity (1.71 and 1.61 times of the control (PPAR-α + PPRE, p < 0.001)). In the NF-κB luciferase assay, 1 suppressed NF-κB activity the most (56.83% at 5 µM; 74.96% at 10 µM; 79.86% at 50 µM). In addition, 1 and 2 inhibited the mRNA expression of NF-κB target genes, including Il6, Mcp1, and Tnfa, at 50 µM, and 3 suppressed the genes at the mRNA level in a dose-dependent manner. We report that 1 and 2 exert anti-inflammatory effects through NF-κB inhibition, and the PPAR-α/NF-κB signaling pathway is related to the anti-inflammatory activity of 3.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Pharmaceuticals (Basel) Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Pharmaceuticals (Basel) Ano de publicação: 2023 Tipo de documento: Article